Literature DB >> 19890023

Effect of body mass index on peak growth hormone response to provocative testing in children with short stature.

Takara L Stanley1, Lynne L Levitsky, Steven K Grinspoon, Madhusmita Misra.   

Abstract

CONTEXT: Obesity is associated with decreased spontaneous and stimulated GH secretion, but the effect of body mass index (BMI) on results of GH stimulation testing in children with short stature is not known.
OBJECTIVE: The aim of the study was to determine the impact of BMI on peak GH to provocative testing in children with short stature. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective review of provocative GH testing performed in 116 children 2-18 yr old in the ambulatory clinic of the Pediatric Endocrinology Unit at the Massachusetts General Hospital from 2004-2008. MAIN OUTCOME MEASURES: The main outcome measure was peak stimulated GH. Height, weight, IGF-I, and IGF-binding protein 3 were also measured.
RESULTS: In univariate regression analysis, BMI sd score (BMI SDS) was inversely associated with natural log (ln) peak GH to provocative testing (P = 0.002), whereas height SDS, ln IGF-I, and IGF-binding protein 3 were not significantly associated with ln peak GH. After controlling for age, gender, BMI, and pubertal status, BMI (P = 0.002) remained independently associated with ln peak GH. BMI SDS significantly influenced the likelihood of diagnosis of GH deficiency using peak GH cutoffs of 10, 7, and 5 microg/liter.
CONCLUSION: In children with short stature, BMI affects peak stimulated GH and should be considered when interpreting GH testing. Higher BMI SDS, even within the normal range, may lead to overdiagnosis of GH deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890023      PMCID: PMC2795667          DOI: 10.1210/jc.2009-1369

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy.

Authors:  Mario Malerba; Simonetta Bossoni; Alessandro Radaeli; Erica Mori; Giuseppe Romanelli; Claudio Tantucci; Andrea Giustina; Vittorio Grassi
Journal:  Bone       Date:  2005-09-08       Impact factor: 4.398

2.  Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children.

Authors:  G Radetti; M Bozzola; B Pasquino; C Paganini; A Aglialoro; C Livieri; A Barreca
Journal:  Metabolism       Date:  1998-12       Impact factor: 8.694

3.  Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.

Authors:  Klaus Mann; Wolfgang Rossbach; Matthias J Müller; Florian Müller-Siecheneder; Tobias Pott; Iris Linde; Ralf W Dittmann; Christoph Hiemke
Journal:  Psychoneuroendocrinology       Date:  2005-09-26       Impact factor: 4.905

4.  Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment.

Authors:  Mario Malerba; Simonetta Bossoni; Alessandro Radaeli; Erica Mori; Stefania Bonadonna; Andrea Giustina; Claudio Tantucci
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

5.  Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.

Authors:  Vera Popovic; Mirjana Doknic; Nadja Maric; Sandra Pekic; Aleksandar Damjanovic; Dragana Miljic; Srdjan Popovic; Natasa Miljic; Marina Djurovic; Miroslava Jasovic-Gasic; Carlos Dieguez; Felipe F Casanueva
Journal:  Neuroendocrinology       Date:  2007-06-15       Impact factor: 4.914

6.  BMI, waist-circumference and waist-hip-ratio as diagnostic tests for fatness in adolescents.

Authors:  M Neovius; Y Linné; S Rossner
Journal:  Int J Obes (Lond)       Date:  2005-02       Impact factor: 5.095

7.  Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans.

Authors:  M Dépôt; G Caillé; J Mukherjee; M A Katzman; A Cadieux; J Bradwejn
Journal:  Neuropsychopharmacology       Date:  1999-02       Impact factor: 7.853

8.  Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.

Authors:  Andrea L Utz; Ami Yamamoto; Linda Hemphill; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-04-29       Impact factor: 5.958

9.  Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.

Authors:  Madhusmita Misra; Miriam A Bredella; Patrika Tsai; Nara Mendes; Karen K Miller; Anne Klibanski
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-10       Impact factor: 4.310

10.  GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.

Authors:  John D Carmichael; Ann Danoff; Daniela Milani; Ronenn Roubenoff; Martin L Lesser; Elayne Livote; Richard E Reitz; Steven Ferris; David L Kleinberg
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

View more
  28 in total

1.  Somatic growth of lean children: the potential role of sleep.

Authors:  Yan-Rui Jiang; Karen Spruyt; Wen-Juan Chen; Xiao-Ming Shen; Fan Jiang
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

Review 2.  Short and tall stature: a new paradigm emerges.

Authors:  Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

3.  Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency.

Authors:  Philip G Murray; Adam Stevens; Chiara De Leonibus; Ekaterina Koledova; Pierre Chatelain; Peter E Clayton
Journal:  JCI Insight       Date:  2018-04-05

4.  Clonidine and glucagon stimulation for testing growth hormone secretion in children and adolescents: can we make it with fewer samples?

Authors:  A Christoforidis; P Triantafyllou; A Slavakis; G Katzos
Journal:  J Endocrinol Invest       Date:  2013-07-23       Impact factor: 4.256

Review 5.  Diagnosis of growth hormone deficiency in childhood.

Authors:  Takara Stanley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-02       Impact factor: 3.243

Review 6.  Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.

Authors:  Paulo F Collett-Solberg; Geoffrey Ambler; Philippe F Backeljauw; Martin Bidlingmaier; Beverly M K Biller; Margaret C S Boguszewski; Pik To Cheung; Catherine Seut Yhoke Choong; Laurie E Cohen; Pinchas Cohen; Andrew Dauber; Cheri L Deal; Chunxiu Gong; Yukihiro Hasegawa; Andrew R Hoffman; Paul L Hofman; Reiko Horikawa; Alexander A L Jorge; Anders Juul; Peter Kamenický; Vaman Khadilkar; John J Kopchick; Berit Kriström; Maria de Lurdes A Lopes; Xiaoping Luo; Bradley S Miller; Madhusmita Misra; Irene Netchine; Sally Radovick; Michael B Ranke; Alan D Rogol; Ron G Rosenfeld; Paul Saenger; Jan M Wit; Joachim Woelfle
Journal:  Horm Res Paediatr       Date:  2019-09-12       Impact factor: 2.852

7.  Comparison of the effects of the L-dopa and insulin tolerance tests on cortisol secretion.

Authors:  S Acar; A Paketçi; H Tuhan; K Demir; E Böber; A Abaci
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

8.  Pituitary imaging in 129 children with growth hormone deficiency: A spectrum of findings.

Authors:  Rushaid N A AlJurayyan; Nasir A M AlJurayyan; Hala G Omer; Sharifah D A Alissa; Hessah M N AlOtaibi; Reem A H AlKhalifah; Amir M I Babiker; Sarar Mohamed
Journal:  Sudan J Paediatr       Date:  2017

9.  A pilot study of the effects of niacin administration on free fatty acid and growth hormone concentrations in children with obesity.

Authors:  O A Galescu; M K Crocker; A M Altschul; S E Marwitz; S M Brady; J A Yanovski
Journal:  Pediatr Obes       Date:  2016-09-21       Impact factor: 4.000

10.  Blunted response to a growth hormone stimulation test is associated with unfavorable cardiovascular risk factor profile in childhood cancer survivors.

Authors:  Anna Petryk; K Scott Baker; Brigitte Frohnert; Antoinette Moran; Lisa Chow; Alan R Sinaiko; Lyn M Steffen; Joanna L Perkins; Lei Zhang; James S Hodges; Julia Steinberger
Journal:  Pediatr Blood Cancer       Date:  2012-09-21       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.